Tokyo Tape
Sign in
← Japan Tobacco

Quarterly report · Q1

2914.TEDINET S100TDT5
Period2024-01-01 → 2024-03-31
Filed2024-05-09
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥740.3bn2024-01-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥2.84T2023-01-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥665.3bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Operating income¥215.8bn2024-01-01 → 2024-03-31Cons.Operating profit loss IFRS
Operating income¥206.4bn2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Profit before tax¥201.3bn2024-01-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax¥621.6bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥183.1bn2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥157.3bn2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥482.3bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥144.7bn2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥157.8bn2024-01-01 → 2024-03-31Cons.Profit loss IFRS
Net income¥485.3bn2023-01-01 → 2023-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥145.2bn2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Total assets¥7.16Tat 2024-03-31Cons.Assets IFRS
Total assets¥7.28Tat 2023-12-31Cons.Assets IFRS
Total assets¥6.35Tat 2023-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.09Tat 2024-03-31Cons.Liabilities IFRS
Total liabilities¥3.37Tat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥4.07Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥3.91Tat 2023-12-31Cons.Equity IFRS
Net assets / equity¥3.59Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥3.62Tat 2022-12-31dCons.Equity IFRS
Equity (owners)¥3.99Tat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.83Tat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥766.9bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.04Tat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥665.2bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥866.9bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥61.8bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥567.0bn2023-01-01 → 2023-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥55.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥27.7bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥126.1bn2023-01-01 → 2023-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥41.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥341.2bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥270.5bn2023-01-01 → 2023-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥196.4bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥88.582024-01-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥271.692023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥81.522023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥88.572024-01-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥271.632023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥81.492023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio55.7%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio52.6%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio55.3%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 68
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-03-31¥1.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-03-31¥322m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-03-31¥705m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥11.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥11.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥9.3bn
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-03-31−¥774m
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-03-31−¥774m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-03-31¥23.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-03-31¥23.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2024-01-01 → 2024-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2024-01-01 → 2024-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥6m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2024-01-01 → 2024-03-31¥681.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2024-01-01 → 2024-03-31¥681.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥64m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥231.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥231.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥219.2bn
—segment totalrevenue2024-01-01 → 2024-03-31¥740.1bn
—segment totalrevenue external2024-01-01 → 2024-03-31¥740.0bn
—segment totalrevenue intersegment2024-01-01 → 2024-03-31¥69m
—segment totalsegment profit2024-01-01 → 2024-03-31¥237.7bn
—segment totalsegment profit2024-01-01 → 2024-03-31¥237.7bn
—segment totalsegment profit2024-01-01 → 2024-03-31¥225.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-03-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-03-31¥443m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥654m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.6bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2023-01-01 → 2023-03-31¥604.4bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2023-01-01 → 2023-03-31¥604.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥61m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥208.8bn
—segment totalrevenue2023-01-01 → 2023-03-31¥664.9bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥664.8bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥69m
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥217.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 891
ItemContextValueUnit
Equity IFRSPrior1QuarterInstant_ShareAcquisitionRightsIFRSMember889000000JPY
Equity IFRSPrior1QuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember109385000000JPY
Equity IFRSPrior1QuarterInstant_EffectivePortionOfCashFlowHedgesIFRSMember6670000000JPY
Equity IFRSPrior1QuarterInstant_jpcrp040300-q1r_E00492-000HedgeCostsIFRSMember－JPY
Equity IFRSPrior2YearInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember8966000000JPY
Equity IFRSPrior2YearInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember104309000000JPY
Equity IFRSPrior2YearInstant_RetainedEarningsIFRSMember3089909000000JPY
Equity IFRSPrior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember3540435000000JPY
Equity IFRSPrior2YearInstant_NonControllingInterestsIFRSMember76326000000JPY
Equity IFRSPrior2YearInstant3616761000000JPY
Profit loss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember144684000000JPY
Profit loss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember144684000000JPY
Profit loss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember542000000JPY
Profit loss IFRSPrior1YTDDuration145226000000JPY
Other comprehensive income IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember1013000000JPY
Other comprehensive income IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember22038000000JPY
Other comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember22038000000JPY
Other comprehensive income IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember3047000000JPY
Other comprehensive income IFRSPrior1YTDDuration25086000000JPY
Comprehensive income IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember1013000000JPY
Comprehensive income IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember22038000000JPY
Comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember144684000000JPY
Comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember166722000000JPY
Comprehensive income IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember3589000000JPY
Comprehensive income IFRSPrior1YTDDuration170311000000JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-0JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration-0JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember-112000000JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-33000000JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember0JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration0JPY
Share based payments ss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Share based payments ss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Share based payments ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Share based payments ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass